نتایج جستجو برای: riba

تعداد نتایج: 559  

ژورنال: :مجله بین المللی علوم آزمایشگاهی 0
سیده فاطمه شمس seyyede fatemeh shams زهرا اریان پور zahra arian pour فرزاد ملاحسینی فومنی farzad molahosseini foomani حسین قلی نوری hossein gholi noori

مقدمه: شیوع ویروس نقص ایمنی انسانی (hiv)به سرعت در دنیا در حال گسترش است. آلودگی با این ویروس منجر به مهار سیستم ایمنی و نهایتا سیندرم نقص ایمنی اکتسابی می شود. تشخیص اولیه ی بیماری با شناسایی آنتی بادی علیه ویروس به روش الایزا (elisa)انجام می شود. برخی تست های تکمیلی بعنوان مثال وسترن بلات و آزمون ایمنوبلاتینگ نوترکیب (riba) برای تایید عفونت ویروسی مورد استفاده قرار می گیرد. بسیاری از نتایج تس...

Journal: :Clinical chemistry 2003
D Robert Dufour Mageli Talastas Maria D A Fernandez Barbara Harris Doris B Strader Leonard B Seeff

BACKGROUND Tests for hepatitis C antibodies (anti-HCV enzyme immunoassays) are usually described as positive or negative. Several studies, mainly in blood donors, have found that specimens with low signal/cutoff (S/C) ratios are commonly negative when tested with a recombinant immunoblot assay (RIBA) or for HCV RNA. METHODS We retrospectively reviewed 17 418 consecutive anti-HCV results from ...

Journal: :The Journal of infectious diseases 2012
Robert D Allison Cathy Conry-Cantilena Deloris Koziol Cathy Schechterly Paul Ness Joan Gibble David E Kleiner Marc G Ghany Harvey J Alter

BACKGROUND A total of 738 volunteer blood donors who were positive for anti-hepatitis C virus (HCV) were assessed for risk factors and outcomes for up to 15 years within the study and up to 54 years from the estimated onset of infection. METHODS A third-generation recombinant immunoblot assay (RIBA) was performed to distinguish true from false anti-HCV reactivity. Findings of HCV polymerase c...

2016
Jungwon Hyun Dae-Hyun Ko Hee Jung Kang Dong Hee Whang Young Joo Cha Hyun Soo Kim

BACKGROUND Anti-hepatitis C virus antibody (anti-HCV) assays are recommended for screening HCV-infected persons. The VIDAS Anti-HCV Assay (bioMérieux, France), based on the enzyme-linked fluorescence test principle, was recently introduced in Korea. We evaluated the clinical performance of the VIDAS assay. METHODS One hundred HCV-positive and 1,002 HCV-negative blood samples confirmed by Arch...

Journal: :Katre, Uluslararasi Insan Arastirmalari Dergisi 2017

Journal: :Clinical and vaccine immunology : CVI 2012
Marco Moretti Barbara Pieretti Annamaria Masucci Davide Sisti Marco Rocchi Ernesto Delprete

We reviewed results from 12,800 samples tested for hepatitis C virus (HCV) antibody detection in our laboratory by screening (Ortho chemiluminescence immunoassay [CIA]) and supplemental tests (Chiron recombinant immunoblot assay [RIBA]). We found that a signal-to-cutoff (S/Co) ratio of 10.3 was, in our setting, the most efficient cutoff point to improve the diagnostic algorithm of HCV infection.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید